Why the study?
Does neuromuscular monitoring reduce persistent neuromuscular blockade in patients receiving neuromuscular blocking drugs?
Does neuromuscular monitoring reduce persistent neuromuscular blockade in patients receiving neuromuscular blocking drugs?
Neuromuscular monitoring should be routinely used when neuromuscular blocking drugs are administered to prevent persistent postoperative blockade.
Answers are grounded in this paper and cite their sources.
May support routine neuromuscular monitoring to reduce residual blockade; leaves open confirmation by randomized trials.
Persistent neuromuscular blockade is not uncommon in the recovery room and contributes to postoperative morbidity and possibly mortality. The use of neuromuscular monitoring and intermediate rather than long-acting neuromuscular blocking drugs have been shown to reduce its incidence. Clinically available methods of detecting and quantitating neuromuscular blockade are reviewed. The writer concludes that such monitoring should be routine when neuromuscular blocking drugs are used.
No takes yet. Share an insight, caveat, or question.
T. A. Torda (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: